These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
Based on these promising results, Johnson & Johnson plans to move the program into a Phase 3 trial to further investigate subcutaneous amivantamab
These findings follow positive Phase 3 results presented earlier this year
mRNA-4359 advances to phase 2 following encouraging results in checkpoint inhibitor-resistant Melanoma
Harmonisation of listing structure requires a direct listing of AstraZeneca shares on the NYSE in place of existing US ADRs
The medicine was well tolerated, with no unexpected safety issue
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
